The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[5-(4-Fluoro-phenyl)-2-(1-methyl-piperidin-4-yl)-1H-imidazol-4-yl]-pyridine ID: ALA365076
PubChem CID: 11500956
Max Phase: Preclinical
Molecular Formula: C20H21FN4
Molecular Weight: 336.41
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)CC1
Standard InChI: InChI=1S/C20H21FN4/c1-25-12-8-16(9-13-25)20-23-18(14-2-4-17(21)5-3-14)19(24-20)15-6-10-22-11-7-15/h2-7,10-11,16H,8-9,12-13H2,1H3,(H,23,24)
Standard InChI Key: XIRXPGXOBQGWNW-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
2.9292 -2.1875 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.1167 -2.3375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.0042 -3.1542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.7542 -3.5042 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.3167 -2.9000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2917 -3.5750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7542 -3.3250 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.1375 -3.0417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5417 -1.7417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4167 -0.5542 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.5750 -3.1750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3042 -4.4042 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4167 -3.8167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6625 -2.4167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4667 -2.5542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2292 -3.9625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1250 -4.4250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1333 -3.5917 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.5917 -4.8292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.8375 -4.8542 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
6.5667 -3.4542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2042 -0.3542 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1875 -1.3417 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7750 -0.9500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.7500 -1.9375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 2 0
4 5 2 0
5 1 1 0
6 3 1 0
7 15 1 0
8 5 1 0
9 2 1 0
10 23 2 0
11 6 2 0
12 6 1 0
13 8 1 0
14 8 1 0
15 14 1 0
16 13 1 0
17 19 1 0
18 11 1 0
19 12 2 0
20 17 1 0
21 7 1 0
22 24 2 0
23 25 1 0
24 9 1 0
25 9 2 0
3 4 1 0
16 7 1 0
22 10 1 0
18 17 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 336.41Molecular Weight (Monoisotopic): 336.1750AlogP: 4.09#Rotatable Bonds: 3Polar Surface Area: 44.81Molecular Species: BASEHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.83CX Basic pKa: 9.03CX LogP: 2.99CX LogD: 1.35Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.78Np Likeness Score: -1.20
References 1. Biftu T, Feng D, Ponpipom M, Girotra N, Liang GB, Qian X, Bugianesi R, Simeone J, Chang L, Gurnett A, Liberator P, Dulski P, Leavitt PS, Crumley T, Misura A, Murphy T, Rattray S, Samaras S, Tamas T, Mathew J, Brown C, Thompson D, Schmatz D, Fisher M, Wyvratt M.. (2005) Synthesis and SAR of 2,3-diarylpyrrole inhibitors of parasite cGMP-dependent protein kinase as novel anticoccidial agents., 15 (13): [PMID:15922595 ] [10.1016/j.bmcl.2005.04.060 ]